Log in

Relevant bibliographies by topics / Mometasome furoate / Journal articles

To see the other types of publications on this topic, follow the link: Mometasome furoate.

Journal articles on the topic 'Mometasome furoate'

Author: Grafiati

Published: 5 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Mometasome furoate.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Altuntaş, Ebru, Gülgün Yener, Remzi Doğan, Fadlullah Aksoy, Mehmet Şerif Aydın, and Ersin Karataş. "Effects of a Thermosensitive In Situ Gel Containing Mometasone Furoate on a Rat Allergic Rhinitis Model." American Journal of Rhinology & Allergy 32, no. 3 (2018): 132–38. http://dx.doi.org/10.1177/1945892418764951.

Full text

Abstract:

Background Mometasone furoate, one of the second generation intranasal corticosteroids, is currently used in suspension form due to its poor solubility. However, this is not favorable for nasal application because of the rapid elimination of the instilled drug from the nasal cavity by mucociliary clearance and delayed onset of action due to the slow dissolution of drug in suspension. Objective The aim of this study was to determine the antiallergic effects of mucoadhesive thermosensitive in situ gel containing mometasone furoate that we developed previously to prolong the contact between the d

APA, Harvard, Vancouver, ISO, and other styles

2

Kurniawan, Agus, Stephani Linggawan, Endang Retnoningsih, Rus Suheryanto, Edi Handoko, and Soehartono Soehartono. "Mometasone furoate topikal menurunkan kadar IL3, IL9-serum dan jumlah eosinofil mukosa hidung penderita rinitis alergi." Oto Rhino Laryngologica Indonesiana 43, no. 2 (2014): 131. http://dx.doi.org/10.32637/orli.v43i2.70.

Full text

Abstract:

Latar belakang: Rinitis alergi merupakan inflamasi kronis mukosa hidung yang diperantarai oleh IgE, sering berhubungan dengan banyak ko-morbid dan berdampak pada kualitas hidup. Interleukin (IL)3 dan IL9 berperan dalam proses pembentukan eosinofil, sedangkan eosinofil diketahui berperan penting dalam menyebabkan keluhan hidung buntu dan kerusakan epitel mukosa hidung penderita rinitis alergi. Mometasone furoate merupakan kortikosteroid topikal generasi terbaru yang jarang menyebabkan efek samping.Tujuan: Penelitian ini bertujuan mengetahui perubahan kadar IL3, IL9-serum, dan jumlah eosinofil m

APA, Harvard, Vancouver, ISO, and other styles

3

Arintowibowo, Amaandika Galih, Ririn Sumiyani, and Kusuma Hendrajaya. "Validation of Mometasone furoate and CIP100 Residue Analysis Methods After Cleaning of Production Equipment in the “XYZ” Pharmaceutical Industry." Jurnal Kimia Sains dan Aplikasi 22, no. 4 (2019): 150–56. http://dx.doi.org/10.14710/jksa.22.4.150-156.

Full text

Abstract:

In this study, the HPLC and Total Organic Carbon (TOC) analysis methods have been developed and validated for the determination of the amount of Mometasone furoate and CIP100 residues on the surface of production equipment and to confirm the efficiency of the cleaning procedure. Mometasone furoate and CIP100 have been chosen based on the worst case assessment approach. The limit of mometasone furoate contamination that has been determined is 100 ug/swab and the specified limit of CIP100 contamination is 100 ug/swab which should not be exceeded during sequential cleaning of the equipment. Momet

APA, Harvard, Vancouver, ISO, and other styles

4

Ronchetti, Riccardo, Luigi Alfonso Pannone, Bruno Cerra, et al. "Multi-Gram Scale Synthesis and Characterization of Mometasone Furoate EP Impurity C." Molecules 28, no. 23 (2023): 7859. http://dx.doi.org/10.3390/molecules28237859.

Full text

Abstract:

Mometasone furoate is a synthetic corticosteroid used in the treatment of skin inflammatory conditions, hay fever and asthma. The industrial manufacturing routes to mometasone furoate are generally accompanied by the formation of numerous process impurities that need to be detected and quantified, as requested by regulatory authorities. The ready availability of such impurities in the required quantity and purity is therefore essential for toxicological studies, analytical method development and process validation. Herein, we report the multi-gram scale preparation of 21′-chloro-(16′α-methyl-3

APA, Harvard, Vancouver, ISO, and other styles

5

Onrust, Susan V., and Harriet M. Lamb. "Mometasone Furoate." Drugs 56, no. 4 (1998): 725–45. http://dx.doi.org/10.2165/00003495-199856040-00018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Baldwin, Claudine M., and Lesley J. Scott. "Mometasone Furoate." Drugs 68, no. 12 (2008): 1723–39. http://dx.doi.org/10.2165/00003495-200868120-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Aladhab, Ya A. "A Randomized Controlled Trial Comparing Budesonide and Mometasone Furoate Nasal Spray in the Treatment of Chronic Rhinosinusitis with Nasal Polyposis: Evaluating Symptom Scores and Quality of Life." Russian Rhinology 33, no. 1 (2025): 12. https://doi.org/10.17116/rosrino20253301112.

Full text

Abstract:

Background. Chronic rhinosinusitis with nasal polyposis (CRSwNP) is a highly debilitating inflammatory condition that affects many people and considerably reduces their quality of life. The mainstay of medical therapy are the intranasal corticosteroids and among them the most commonly used are budesonide and mometasone furoate. They have been used for a long time; however, only few studies have compared their efficacy. Objective. To compare the efficacy of budesonide and mometasone furoate nasal sprays for the treatment of CRSwNP with validated patient-reported outcome measures in a randomized

APA, Harvard, Vancouver, ISO, and other styles

8

Minshall, E., O. Ghaffar, L. Cameron, et al. "Assessment by Nasal Biopsy of Long-Term Use of Mometasone Furoate Aqueous Nasal Spray (Nasonex) in the Treatment of Perennial Rhinitis." Otolaryngology–Head and Neck Surgery 118, no. 5 (1998): 648–54. http://dx.doi.org/10.1177/019459989811800514.

Full text

Abstract:

Allergic rhinitis is associated with specific histopathologic changes in the nasal mucosa including squamous metaplasia and local eosinophilia. Previous studies have shown that mometasone furoate aqueous nasal spray is effective and well tolerated in reducing perennial rhinitis and seasonal allergic rhinitis symptoms. We undertook a multicenter, open-label study to evaluate, by nasal biopsy, the tissue changes associated with mometasone furoate use (200 μg/day) during a 12-month treatment period in patients with perennial rhinitis. Of the 69 patients enrolled in the study, 52 completed all 12

APA, Harvard, Vancouver, ISO, and other styles

9

Bakshi, Satvinder Singh, Surianarayanan Gopalakrishnan, and Nirmal Coumare V. "A randomized study comparing the efficacy of mometasone furoate and fluticasone furoate on the ocular and nasal symptoms of allergic rhinitis." International Journal of Otorhinolaryngology and Head and Neck Surgery 3, no. 4 (2017): 918. http://dx.doi.org/10.18203/issn.2454-5929.ijohns20173214.

Full text

Abstract:

<p class="abstract"><strong>Background:</strong> Ocular symptoms like itching, redness and congestion are common in patients with allergic rhinitis. These symptoms affect the quality of life and increase the burden on the healthcare cost. Intranasal steroids are effective in reducing the nasal and ocular symptoms of allergic rhinitis. We aim to compare the efficacy of mometasone furoate nasal spray and fluticasone furoate nasal spray in reducing the nasal and ocular symptoms of allergic rhinitis.</p><p class="abstract"><strong>Methods:</strong> 90 pati

APA, Harvard, Vancouver, ISO, and other styles

10

Karole, Sarita, Akash Sagar, Anup K. Chakraborty, and Kavita R. Loksh. "Formulation, development and characterization of topical organogel of mometasone furoate for the treatment of skin disease." Indian Journal of Pharmacy and Pharmacology 9, no. 1 (2022): 51–56. http://dx.doi.org/10.18231/j.ijpp.2022.009.

Full text

Abstract:

Topical glucocorticoid formulations are widely used for effective treatment and control of a variety of dermatoses. Mometasone furoate is a medium potency, synthetic, non-fluorinated topical corticosteroid, indicated for the relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses including psoriasis. The percutaneous absorption increases risk associated with systemic absorption of topically applied formulation. Controlled release of the drug to the skin could reduce the side effects while reducing percutaneous absorption. Organogels are semi-solid materials,

APA, Harvard, Vancouver, ISO, and other styles

11

Zeng, Ming, Xiao-Bo Long, Yong-Hua Cui, and Zheng Liu. "Comparison of Efficacy of Mometasone Furoate versus Clarithromycin in the Treatment of Chronic Rhinosinusitis without Nasal Polyps in Chinese Adults." American Journal of Rhinology & Allergy 25, no. 6 (2011): e203-e207. http://dx.doi.org/10.2500/ajra.2011.25.3728.

Full text

Abstract:

Background Although both nasal steroids and macrolide antibiotics have been recommended for the treatment of chronic rhinosinusitis without nasal polyps (CRSsNPs), whether there is any difference in their clinical efficacy remains unexplored. In addition, few studies have investigated their clinical efficacy in a Chinese population living in China, who present distinct inflammatory patterns compared with white patients in western countries. This study compares the efficacy of mometasone furoate and clarithromycin treatment in CRSsNP in Chinese adults in a preliminary prospective, open-label, r

APA, Harvard, Vancouver, ISO, and other styles

12

Dhoot, Dhiraj, R. D. Kharkar, Harshal Mahajan, and Hanmant Barkate. "A real world retrospective analysis of comparison of effectiveness and safety of mometasone furoate and fluticasone propionate in the management of eczema and dermatitis." IP Indian Journal of Clinical and Experimental Dermatology 7, no. 2 (2021): 120–24. http://dx.doi.org/10.18231/j.ijced.2021.023.

Full text

Abstract:

Contact dermatitis is one the commonest dermatological condition which is managed by topical corticosteroids. Mid potent topical corticosteroids are commonly prescribed but there is no any comparative data between mometasone furoate and fluticasone propionate in the management of dermatitis.A real world retrospective study was conducted across India to compare the clinical assessment of mometasone 0.1% cream and fluticasone 0.005% cream in the management of contact dermatitis at 236 dermatology clinics.A data of 1106 patients were included in this analysis in which 598 were included in mometas

APA, Harvard, Vancouver, ISO, and other styles

13

Abhishek, Jhariya* Nazneen Dubey Shubhangi Nema Bharti Choudhary. "Formulation And Evaluation Of Emulgel For The Treatment Of Psoriasis." International Journal in Pharmaceutical Sciences 2, no. 8 (2024): 3755–71. https://doi.org/10.5281/zenodo.13371575.

Full text

Abstract:

Psoriasis is chronic inflammatory skin disarray that may drastically affect the feature of life of an affected person. Emulgel is a drug delivery systems found effective in topical delivery. Mometasone is a medium-potency synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. We used physiochemical properties of drug, and an assessment of the irrelevance to the final formulation, the chemical and physical stability of drug and compatibility of the active with potential excipients. A suitable method of analysis of drug was UV spectrophotometric. Mometaso

APA, Harvard, Vancouver, ISO, and other styles

14

Florincescu-Gheorghe, Nona-Aura, Florica Popescu, and D. O. Alexandru. "Treatment Evaluation with Mometasone Furoate, Alone or in Combination with Desloratadine/ Montelukast in Moderate Severe Allergic Rhinitis." Acta Medica Marisiensis 60, no. 3 (2014): 106–8. http://dx.doi.org/10.2478/amma-2014-0022.

Full text

Abstract:

Abstract Introduction: Allergic rhinitis is one of the most common allergic diseases, characterized by the inflammation of the nasal mucosa. Eosinophils play a predominant pro-inflammatory role in allergic inflammation. This study assesses the effect of mometasone furoate alone or in combination with desloratadine/montelukast in patients with moderate-severe allergic rhinitis. Material and method: This is a prospective study that took place over 8 weeks on 70 patients diagnosed with moderate-severe allergic rhinitis with sensitization to the pollen of Ambrosia elatior. The patients were evalua

APA, Harvard, Vancouver, ISO, and other styles

15

Bhattachan, Sushma, Yogesh Neupane, Bibhu Pradhan, and Naramaya Thapa. "Comparison of Outcomes Between Mometasone Furoate Intranasal Spray and Oral Montelukast in Patients with Allergic Rhinitis." Journal of Nepal Health Research Council 18, no. 2 (2020): 268–70. http://dx.doi.org/10.33314/jnhrc.v18i2.2509.

Full text

Abstract:

Background: Allergic rhinitis is a common ailment with rising trend and worldwide prevalence of some 400 million. Methods: This prospective randomized crosssectional study was done at the Department of Otorhinolaryngology and Head and Neck Surgery, Tribhuvan University, Teaching Hospital, Kathmandu, Nepal from June 2016 to August 2017. They were randomly assigned to two groups by lottery method. Group A received mometasone furoate intranasal spray and Group B received oral montelukast for a total duration of one month. Prior to starting medication and one month after medications, total nasal s

APA, Harvard, Vancouver, ISO, and other styles

16

Kochetkov, P. A., Andrey Stanislavovich Lopatin, P. A. Kochetkov, and A. S. Lopatin. "Treatment of nasal polyposis. Mometasone furoate. Review." Russian Journal of Allergy 6, no. 4 (2009): 3–11. http://dx.doi.org/10.36691/rja1017.

Full text

Abstract:

This publication is devoted to review of safety and efficacy of mometasone furoate for treatment of nasal polyposis. Authors present the results of last researches of this topic with high level of evidence. In the article authors review the following questions: system biovialability, using mometasone furoate as monotherapy and after surgery for treating nasal polyposis. Adverse events, safety and the reasons of unsuccessful treating were resumed.

APA, Harvard, Vancouver, ISO, and other styles

17

Madgulkar, Ashwini R., Rahul R. Padalkar, and Sushant K. Amale. "Preformulation Studies of Intranasal Solid Lipid Nanoparticles of Mometasone Furoate." Journal of Drug Delivery and Therapeutics 9, no. 4 (2019): 526–28. http://dx.doi.org/10.22270/jddt.v9i4.3100.

Full text

Abstract:

The objective of the present work was to prepare intranasal solid lipid nanoparticles (SLN) of mometasone furoate. Mometasone furoate is BCS class II drug having low aqueous solubility and highly sensitive to hepatic metabolism. Mometasone furoate loaded nanoparticles were prepared by high pressure homogenization technique. The preformulation studied was conducted by studying various selection criteria. Lipid was chosen on the basis of maximum solubility of the drug in lipid. Glyceryl monostearate was selected as the lipid phase which showed maximum drug solubility than other lipids. Selection

APA, Harvard, Vancouver, ISO, and other styles

18

&NA;. "Fluticasone furoate/mometasone." Reactions Weekly &NA;, no. 1412 (2012): 21–22. http://dx.doi.org/10.2165/00128415-201214120-00078.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Sharpe, Miriam, and Blair Jarvis. "Inhaled Mometasone Furoate." Drugs 61, no. 9 (2001): 1325–50. http://dx.doi.org/10.2165/00003495-200161090-00011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

McCormack, Paul L., and Greg L. Plosker. "Inhaled Mometasone Furoate." Drugs 66, no. 8 (2006): 1151–68. http://dx.doi.org/10.2165/00003495-200666080-00011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Khan, Md Alauddin, Mohammod Abu Hena Chowdhury, Lubna Khondker, and Dilshad Afroze. "Safety of Topical Mometasone Furoate 0.1% Cream vs Topical Tacrolimus 0.03% Ointment in the Treatment of Atopic Dermatitis." Medicine Today 37, no. 1 (2025): 14–18. https://doi.org/10.3329/medtoday.v37i1.79249.

Full text

Abstract:

Introduction: Atopic dermatitis (AD) is an itchy, chronic, or chronically relapsing, inflammatory skin condition, affecting between 10% and 20% of children and 1% and 3% of adults. Atopic dermatitis causes significant physical, psychological and social distress. The prevalence of AD has increased steadily over the last 30 years. Topical steroids and calcineurin inhibitors are the current standard for topical anti-inflammatory therapy. Mometasone furoate cream 0.1% is a medium potency corticosteroid, effective in the treatment of atopic dermatitis in children. Materials and Methods: A clinical

APA, Harvard, Vancouver, ISO, and other styles

22

Tas, Abdullah, Recep Yagiz, Omer Yalcin, et al. "Use of Mometasone Furoate Aqueous Nasal Spray in the Treatment of Rhinitis Medicamentosa: An Experimental Study." Otolaryngology–Head and Neck Surgery 132, no. 4 (2005): 608–12. http://dx.doi.org/10.1016/j.otohns.2005.01.010.

Full text

Abstract:

OBJECTIVE: We aimed to investigate, histopathologic changes in the nasal mucosa of guinea pig's after prolonged administration of oxymetazoline and the development of rhinitis medicamentosa, and the efficacy of mometasone furoate aqueous nasal spray and saline in reversing the ultrastructural changes attributable to rhinitis medicamentosa. METHODS: In the study, 24 male guinea pigs (500 to 600 gr) were used. Oxymetazolin (0.05%) was sprayed into the nasal cavities of the guinea pigs 3 times daily for 8 weeks. At the end of this period, 6 guinea pigs were killed and examined to make sure that t

APA, Harvard, Vancouver, ISO, and other styles

23

Abhishek, Kumar, and Kumar Udayan Uday. "Comparative Efficacy of Tacrolimus and Mometasone Furoate in Topical Treatment for Atopic Dermatitis: A Randomized Controlled Trial." International Journal of Pharmaceutical and Clinical Research 16, no. 2 (2024): 1092–95. https://doi.org/10.5281/zenodo.11077794.

Full text

Abstract:

<strong>Background:</strong> Atopic dermatitis (AD) significantly impacts patients’ quality of life due to symptoms like itchiness and skin inflammation. Tacrolimus and mometasone furoate are commonly used topical treatments for AD, each with unique benefits. While tacrolimus offers effective treatment without long-term steroid side effects, mometasone furoate provides potent anti-inflammatory effects. Comparative studies between these treatments aim to assess their efficacy and safety in managing AD. <strong>Methods:</strong> This randomized controlled trial enrolled 70 a

APA, Harvard, Vancouver, ISO, and other styles

24

Tarek, Mohamed, Hebatallah A. Wagdy, Eman S. Elzanfaly, and Sawsan M. Amer. "A Validated Ultra-Performance Liquid Chromatographic Method for the Simultaneous Determination of Nadifloxacin, Mometasone Furoate and Miconazole Nitrate in Their Combined Dosage Form and Spiked Human Plasma Samples." Journal of Chromatographic Science 57, no. 10 (2019): 867–73. http://dx.doi.org/10.1093/chromsci/bmz082.

Full text

Abstract:

Abstract Nadifloxacin, mometasone furoate and miconazole nitrate are formulated together as a topical antifungal dosage form. In this work, a reversed-phase ultra-performance liquid chromatographic method coupled with a diode array detector (RP-UPLC-DAD) was developed and validated to determine nadifloxacin, mometasone furoate and miconazole nitrate simultaneously in their bulk powder, in pharmaceutical preparation and in spiked human plasma samples. Separation was achieved on an ACQUITY UPLC C18 column of 2.2 μm particle size (2.1 × 100 mm) via isocratic elution using a mobile phase consistin

APA, Harvard, Vancouver, ISO, and other styles

25

Taléns-Visconti, Raquel, Matteo Perra, Amparo Ruiz-Saurí, and Amparo Nácher. "New Vehiculation Systems of Mometasone Furoate for the Treatment of Inflammatory Skin Diseases." Pharmaceutics 14, no. 12 (2022): 2558. http://dx.doi.org/10.3390/pharmaceutics14122558.

Full text

Abstract:

A pre-formulation study was carried out to obtain liposomal formulations of mometasone furoate as an alternative system to marketed forms of corticosteroid for the treatment of inflammatory skin lesions. Mometasone furoate was loaded in glycerosomes and glyceroethosomes, which were also modified with hyaluronic acid (glyceroethohyalurosomes). Vesicles were designed, elaborated, and characterized, and their biocompatibility, efficacy against oxidative stress and skin lesions were assessed in vitro, in human epidermal cells, and in vivo, in a mouse skin epidermal hyperplasia model. All formulati

APA, Harvard, Vancouver, ISO, and other styles

26

Yang, Huan, Hong Shu, Limin Miao, et al. "482 - Efficacy and safety of sequential topical 0.1% mometasone furoate cream and 2% crisaborole in the treatment of mild to moderate atopic dermatitis in children aged over 2 years—a multicentre parallel randomised controlled study in China." British Journal of Dermatology 190, Supplement_2 (2024): ii1. http://dx.doi.org/10.1093/bjd/ljad498.001.

Full text

Abstract:

Abstract Background Atopic dermatitis (AD) is a chronic, recurrent pruritic, inflammatory skin disease associated with genetic allergies. Crisaborole is a phosphodiesterase 4 (PDE4) inhibitor approved by the US Food and Drug Administration for the treatment of patients over 2 years of age with mild to moderate AD. Previous studies have focused on the efficacy of crisaborole in the treatment of AD, and its influence on AD recurrence is not clear. Objective To explore the efficacy and safety of sequential topical 0.1% mometasone furoate cream (Elosone) and crisaborole in the treatment of mild to

APA, Harvard, Vancouver, ISO, and other styles

27

Zhang, Yufeng, Tao Huang, and Zhongfang Xia. "Biyuantongqiao Granules Combined with Mometasone Furoate Nasal Spray for Allergic Rhinitis in Children." Current Topics in Nutraceutical Research 20, no. 4 (2022): 630–34. http://dx.doi.org/10.37290/ctnr2641-452x.20:630-634.

Full text

Abstract:

The present study was conducted to observe the clinical efficacy of biyuantongqiao granules combined with mometasone furoate nasal spray in the treatment of allergic rhinitis in children. The patients in the control group were treated with mometasone furoate nasal spray (50 µg/press), and the patients in the observation group received biyuantongqiao granules (15 g × 10 bags) combined with mometasone furoate nasal spray, 15 mg/time. The total effective rate was significantly higher in the observation group (95.35%) than the control group (79.06%). The visual analogue scale scores in the two gro

APA, Harvard, Vancouver, ISO, and other styles

28

Emelyanov, A. V., and L. A. Goryachkina. "Mometasone furoate dry powder inhaler for the treatment of asthma." Russian Journal of Allergy 9, no. 4 (2012): 79–87. http://dx.doi.org/10.36691/rja743.

Full text

Abstract:

The review is focused on inhaled mometasone furoate (Asmanex Twisthaler), a new medication for the treatment of asthma in adults and childred (12 years and older). Mometasone furoate (MF) has high antiinflammatory activity and low systemic bioavalability. MF has an excellent safety and efficacy profile in approved doses 200—800 mcg/daily od (in the evening) or bid (in the morning and in the evening). For patients with persistent asthma required treatment with an inhaled corticosteroid, MF is an excellent therapeutic choice.

APA, Harvard, Vancouver, ISO, and other styles

29

Rizzi, Angela, Giuseppe Parrinello, Eugenio De Corso, et al. "Mometasone Furoate in Non-Allergic Rhinitis: A Real-Life Italian Study." Journal of Personalized Medicine 12, no. 7 (2022): 1179. http://dx.doi.org/10.3390/jpm12071179.

Full text

Abstract:

Background: In order to evaluate the efficacy of intranasal mometasone furoate in patients with non-allergic rhinitis (NAR), a real-life, observational, prospective study is performed. Methods: Thirty-one patients (age 18–64 years) receive intranasal (mometasone furoate, 200 µg b.i.d. for 15 consecutive days per month for 6 consecutive months), plus isotonic nasal saline. The cytologic pattern of local inflammation, nasal airflow, through peak nasal inspiratory flow (PNIF), quality of life (QoL), through the rhinitis quality of life questionnaire (RQLQ), the sinonasal outcome test (SNOT-22), t

APA, Harvard, Vancouver, ISO, and other styles

30

Hintschich, Constantin A., Melanie Dietz, Antje Haehner, and Thomas Hummel. "Topical Administration of Mometasone Is Not Helpful in Post-COVID-19 Olfactory Dysfunction." Life 12, no. 10 (2022): 1483. http://dx.doi.org/10.3390/life12101483.

Full text

Abstract:

Persistent olfactory dysfunction is a major concern post-COVID-19, affecting up to 5% of all patients. Different therapeutic options, including mometasone nasal spray, have been recommended, only some of which have been validated for post-COVID-19 olfactory dysfunction. In this study we psychophysically assessed the effect of intranasally applied mometasone furoate on the recovery of olfaction. The spray was applied with a long applicator so that the olfactory cleft could be reached effectively. After olfactory dysfunction had been confirmed psychophysically using Sniffin’ Sticks, patients wer

APA, Harvard, Vancouver, ISO, and other styles

31

Faruquee, Mahmud Ullah, Mostafa Mahfuzul Anwar, Kyaw Khin U, et al. "Role of Mometasone Furoate Nasal Spray Combined with Montelukast Sodium in the Treatment of Adenoids Hypertrophy in Children." Journal of Chittagong Medical College Teachers' Association 32, no. 2 (2021): 59–63. http://dx.doi.org/10.3329/jcmcta.v32i2.66481.

Full text

Abstract:

Background: Adenoidectomy is currently considered the treatment of choice for children with severe symptoms caused by Adenoids Hypertrophy (AH). Non-surgical alternative treatment options are considered in less severe cases to avoid the untoward effect of surgery. This study was aimed to evaluate the efficacy and safety of Mometasone Furoate nasal spray combined with Montelukast Sodium in children with AH. Materials and methods: This trial included 118 patients aged 3 to 13 years having symptomatic AH from the OPD of Otolaryngology and Head Neck Surgery of CMCH from May 2019 to April 202

APA, Harvard, Vancouver, ISO, and other styles

32

Aneeza, W. Hamizan, Salina Husain, Roslenda Abdul Rahman, Dexter Van Dort, Asma Abdullah, and Balwant S. Gendeh. "Efficacy of Mometasone Furoate and Fluticasone Furoate on Persistent Allergic Rhinoconjunctivitis." Allergy & Rhinology 4, no. 3 (2013): ar.2013.4.0065. http://dx.doi.org/10.2500/ar.2013.4.0065.

Full text

Abstract:

Allergic rhinoconjunctivitis denotes both nasal and ocular manifestation of allergy, which may be solely treated with intranasal steroid. This study compares the efficacy of mometasone furoate nasal spray (NS) and fluticasone furoate NS in treatment of allergic rhinoconjunctivitis. The secondary objective is to study the severity of baseline ocular symptoms in allergic rhinoconjunctivitis. Seventy-eight patients with allergic rhinoconjunctivitis were assessed subjectively and objectively using twice-daily symptom scores for nasal (reflective total nasal symptom score [rTNSS] and instantaneous

APA, Harvard, Vancouver, ISO, and other styles

33

Samantaray, Kabikant, Rajesh Dhir, Sameer Deshmukh, et al. "Comparative clinical assessment of mometasone furoate-azelastine hydrochloride intranasal spray (Ryaltris AZ®) with fluticasone furoate-azelastine hydrochloride intranasal spray in patients with allergic rhinitis in India." International Journal of Otorhinolaryngology and Head and Neck Surgery 9, no. 8 (2023): 637–41. http://dx.doi.org/10.18203/issn.2454-5929.ijohns20232220.

Full text

Abstract:

Background: Allergic rhinitis is a type of IgE-mediated hypersensitivity reaction. ARIA recommends a combination of intranasal corticosteroid and intranasal antihistamine as first-line treatment for allergic rhinitis in moderate to severe AR. The current study aimed to compare the effectiveness and safety of Mometasone furoate-Azelastine hydrochloride Nasal Spray and Fluticasone furoate-Azelastine hydrochloride Nasal Spray for the treatment of allergic rhinitis in India. Methods: A multicentric, comparative study was carried out across 30 ENT clinics in India. From September to November 2022,

APA, Harvard, Vancouver, ISO, and other styles

34

Filimonova, Tat'yana Mikhaylovna, O. G. Elisyutina, E. S. Fedenko, et al. "THE INFLUENCE OF TOPICAL GLUCOCORTICOSTEROIDS ONCYTOKINE GENE EXPRESSION IN THE SKIN AND PERIPHERALBLOOD OF ATOPIC DERMATITIS PATIENTS." Russian Journal of Allergy 8, no. 3 (2011): 19–30. http://dx.doi.org/10.36691/rja779.

Full text

Abstract:

Background. To investigate the influence of mometasone furoate 0,1% cream on cytokine gene expression in the skin and peripheral blood of atopic dermatitis (AD) patients comparing with control. Material and methods. 40 AD patients were included in the study and divided into 2 groups. group 1 patients were given continuous course of mometasone furoate 0,1% cream treatment for 14 days. group 2 patients were given indifferent emollient elobase cream for 14 days. Clinical efficacy of the treatment was assessed on the following features: SCORAD index, Investigators global Assessment (IgA) score and

APA, Harvard, Vancouver, ISO, and other styles

35

Zitt, Myron, Teddy Kosoglou, and James Hubbell. "Mometasone Furoate Nasal Spray." Drug Safety 30, no. 4 (2007): 317–26. http://dx.doi.org/10.2165/00002018-200730040-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Kelly, H. William. "Mometasone Furoate Inhalation Powder." Pediatric Asthma, Allergy & Immunology 18, no. 3 (2005): 167–69. http://dx.doi.org/10.1089/pai.2005.18.167.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Weinstein, Cindy L. J., Nicholas Ryan, Tulin Shekar, et al. "Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate." Journal of Allergy and Clinical Immunology 143, no. 4 (2019): 1395–402. http://dx.doi.org/10.1016/j.jaci.2018.10.065.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Islam, Md Zohurul, Martyna Krajewska, Krystyna Prochaska, and Suvash C. Saha. "In vitro and in silico studies of the interaction between glucocorticoid drug mometasone furoate and model lung surfactant monolayer." RSC Advances 15, no. 8 (2025): 5951–64. https://doi.org/10.1039/d5ra00004a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Choi, Kevin J., David W. Jang, Ali R. Zomorodi, Patrick J. Codd, Allan Friedman, and Ralph Abi Hachem. "Novel Application of Steroid Eluting Stent in Petrous Apex Cholesterol Granuloma." Journal of Neurological Surgery Part B: Skull Base 80, no. 05 (2018): 500–504. http://dx.doi.org/10.1055/s-0038-1675751.

Full text

Abstract:

Abstract Objective This study describes the safety and efficacy of mometasone furoate eluting stents in the management of petrous apex cholesterol granuloma approached through an endonasal endoscopic route and assesses the restenosis rate. Methods Consecutive patients undergoing endoscopic endonasal marsupialization of a petrous apex cholesterol granuloma at a tertiary referral center who had a mometasone furoate eluting stent placed intraoperatively were reviewed in a retrospective fashion. Postoperative endoscopy was used to determine success of surgery and stenting. Results Five patients we

APA, Harvard, Vancouver, ISO, and other styles

40

Bangiyev, John N., Nandini Govil, Anthony Sheyn, Michael Haupert, and Prasad John Thottam. "Novel Application of Steroid Eluting Stents in Choanal Atresia Repair." Annals of Otology, Rhinology & Laryngology 126, no. 1 (2016): 79–82. http://dx.doi.org/10.1177/0003489416671533.

Full text

Abstract:

Purpose: To describe the application of mometasone furoate eluting sinus stent technology in the treatment of choanal atresia (CA) in the hopes of preventing postsurgical stenosis. Methods: We analyzed 3 consecutive patients aged 4 days to 16 years undergoing repair of CA at a tertiary pediatric hospital. Mometasone furoate eluting sinus stents were placed intraoperatively. Postoperative need for revision surgery as well as routine surveillance endoscopy were used to determine success of surgery. Results: Three patients of varying age and etiology underwent successful repair of choanal atresia

APA, Harvard, Vancouver, ISO, and other styles

41

Vuralkan, Erkan, Cem Saka, Istemihan Akin, et al. "Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps." Therapeutic Advances in Respiratory Disease 6, no. 1 (2011): 5–10. http://dx.doi.org/10.1177/1753465811427577.

Full text

Abstract:

Background: The aim of our study was to compare the effects of montelukast and mometasone furoate nasal spray on the postoperative course of patients with nasal polyposis. Patients and methods: Fifty patients diagnosed with nasal polyposis between March 2006 and August 2007 were included in the study. All patients underwent bilateral endoscopic sphenoethmoidectomy and were randomized postoperatively into two groups. Group A ( n = 25) received 10 mg montelukast per day and group B ( n = 25) received 400 µg mometasone furoate nasal spray twice daily. All patients were followed up for 6 months. S

APA, Harvard, Vancouver, ISO, and other styles

42

Lipworth, Brian J. "Mometason Furoate Levels." Chest 120, no. 3 (2001): 1034–35. http://dx.doi.org/10.1378/chest.120.3.1034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Affrime, Melton B. "Mometason Furoate Levels." Chest 120, no. 3 (2001): 1035. http://dx.doi.org/10.1016/s0012-3692(15)50195-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Samtsov, A. V., and A. V. SAMTSOV. "Problems with differential diagnostics of seborrheic dermatitis and plaque psoriasis by the exampleof a particular case study." Vestnik dermatologii i venerologii 87, no. 5 (2011): 98. http://dx.doi.org/10.25208/vdv1071.

Full text

Abstract:

A clinical case of psoriasis with involvement of scalp and armpits areas is presented. Differential diagnosis was made between psoriasis and seborrheic dermatitis. The diagnosis of psoriasis was confirmed morphologically. Mometasone furoate lotion was selected for topical therapy of intertriginous areas (armpits), and the symptoms were eliminated after one week of treatment. For the reason of extensive scaling, betametasone plus salicylic acid lotion was administered to the scalp area, with significant symptoms improvement by 14th day of treatment. This case illustrates the importance of prope

APA, Harvard, Vancouver, ISO, and other styles

45

Altuntaş, Emine Elif, Ömer Tamer Doğan, Bülent Saraç, Nergiz Hacer Turgut, Kasım Durmuş, and Melih Akyol. "The effects of mometasone furoate and strontium chloride in a rat model of allergic rhinitis." Ear, Nose & Throat Journal 97, no. 1-2 (2018): E1—E7. http://dx.doi.org/10.1177/0145561318097001-225.

Full text

Abstract:

Neurogenic inflammation plays a role in the pathophysiology of allergic rhinitis. Highly effective in reducing the sensory irritation caused by some substances, strontium salts directly affect C-type nerve fibers. The aim of this study was to compare the efficacy of mometasone furoate and strontium chloride on early-phase symptoms in a rat model of allergic rhinitis. Wistar albino rats (n = 24) were randomly divided into three groups: the mometasone group, receiving 1 μg mometasone furoate (2 µl/site); the strontium 3% group, receiving 3% strontium chloride (2 μl/site); and the strontium 5% gr

APA, Harvard, Vancouver, ISO, and other styles

46

Govindaraj, Sriram, Ganeshbala Arivazhagan, Jayendiran Subramani, Jinu Vadakkanethu Iype, and Ilango Chakkravarthy. "The role of budesonide and mometasone furoate on the nasal and sinus symptoms in allergic rhinosinuitis: a randomized study." International Journal of Otorhinolaryngology and Head and Neck Surgery 6, no. 1 (2019): 15. http://dx.doi.org/10.18203/issn.2454-5929.ijohns20195193.

Full text

Abstract:

<p class="abstract"><strong>Background:</strong> Allergic rhinosinuitis is one of the common clinical problems that otorhinolaryngologist faces daily. Sinusitis symptoms like headache, facial pain and eyelid oedema are frequent in patients with allergic rhinitis, which in turn will affect the cognitive function, productivity and quality of life which impair the efficiency of the individual work performance. It may result in a prescription for antibiotics but the role of antibiotics is debated. Anti-inflammatory drugs such as intranasal steroids play a major role in reducing t

APA, Harvard, Vancouver, ISO, and other styles

47

Liu, Leo, and Jianguo Shi. "Therapeutic effects investigation of physical therapy and pharmacotherapy in the treatment of persistent allergic rhinitis." Cambridge Science Advance 2024, no. 3 (2024): 28–33. http://dx.doi.org/10.62852/csa/2024/20.

Full text

Abstract:

To investigate the therapeutic effects of physical therapy and pharmacotherapy in the treatment of persistent allergic rhinitis. Methods:192 patients were randomly divided into 3groups, A group 72 cases, B group 70 cases. A and B group were treated with focused ultrasound and radiofrequency ablation respectively under the endoscope and using spraying Mometasone Furoate Nasal Spray for 1month after the operation. Patients of C group use the Mometasone Furoate Nasal Spray and Cetirizine Hydro- chloride Tablets for 1 month. Follow up for 6 months after treatment and evaluate the curative effect w

APA, Harvard, Vancouver, ISO, and other styles

48

Salgado, Ana Cristina Gomes Barros, Alexandra Maria Nunes Nogueira da Silva, Marta Cristina Jorge Cabral Machado, Maria Aida da Silva Costa Duarte, and Helena Margarida de Oliveira Marques Ribeiro. "Development, stability and in vitro permeation studies of gels containing mometasone furoate for the treatment of dermatitis of the scalp." Brazilian Journal of Pharmaceutical Sciences 46, no. 1 (2010): 109–14. http://dx.doi.org/10.1590/s1984-82502010000100012.

Full text

Abstract:

Dermatological inflammatory diseases such as atopic dermatitis, psoriasis and seborrhoeic dermatitis often affect the scalp and the eyebrows. Although there are many dosage forms available, these are particularly critical anatomic regions for application of topical formulations because of the presence of hair. Lotions are therefore the recommended type of drug delivery system for these areas. The presence of hair may limit the application and thus the acceptability of the formulation and its compliance. Because of its low apparent viscosity, lotion application is unpleasant. Gels, given their

APA, Harvard, Vancouver, ISO, and other styles

49

Neher, Andreas, Michaela Gstöttner, Arne Scholtz, and Markus Nagl. "Antibacterial Activity of Mometasone Furoate." Archives of Otolaryngology–Head & Neck Surgery 134, no. 5 (2008): 519. http://dx.doi.org/10.1001/archotol.134.5.519.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Rédai, Emőke Margit, Boglárka Jakab, Robert Alexandru Vlad, et al. "Development of semisolid pharmaceutical forms with mometasone furoate." Acta Marisiensis - Seria Medica 69, no. 4 (2023): 280–84. http://dx.doi.org/10.2478/amma-2023-0045.

Full text

Abstract:

Abstract Objective This study aims to develop semisolid pharmaceutical forms for the topical administration of mometasone furoate. Methods Two creams (O1 and O2) and four hydroxypropyl methylcellulose-based hydrogels were prepared (H3-H6). Two different sorts of hydroxypropyl methylcellulose were used in concentrations of 15 and 20%. Consistency, spreadability, viscosity, and pH were measured. In vitro drug release was determined by a vertical, Franz diffusion cell. Mathematical models were applied for a better understanding of release phenomena. Results O1 and O2 presented lower values for pe

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!